1033905-10-0Relevant articles and documents
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
-
Page/Page column 58-59, (2010/09/05)
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
-
Page/Page column 52, (2008/06/13)
The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.